The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib trial of pembrolizumab (Pembro) following adoptive cell therapy (ACT) in patients with platinum-resistant ovarian cancer; The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) trial.
 
Josee-Lyne Ethier
No Relationships to Disclose
 
Luisa Bonilla
No Relationships to Disclose
 
Sarah Boross-Harmer
No Relationships to Disclose
 
Genevieve Bouchard-Fortier
No Relationships to Disclose
 
Jane Cipollone
No Relationships to Disclose
 
Blaise A. Clarke
No Relationships to Disclose
 
Neesha C. Dhani
Honoraria - Celgene; Sanofi
Consulting or Advisory Role - Celgene; Incyte
 
Alexandra Maria Easson
No Relationships to Disclose
 
Norman Franke
No Relationships to Disclose
 
David Paul Goldstein
Stock and Other Ownership Interests - CVS (I); Johnson & Johnson (I); Merck (I); Pfizer (I)
 
Stephanie Lheureux
Consulting or Advisory Role - AstraZeneca; AstraZeneca
 
Habeeb Majeed
No Relationships to Disclose
 
Taymaa May
No Relationships to Disclose
 
Michael Reedijk
No Relationships to Disclose
 
Marjan Rouzbahman
No Relationships to Disclose
 
Sam Saibil
No Relationships to Disclose
 
Patricia Ann Shaw
No Relationships to Disclose
 
Pamela S Ohashi
Consulting or Advisory Role - Baxalta; Lion Biotechnologies; Providence Pharmaceuticals; Symphony Evolution
 
Linh T. Nguyen
No Relationships to Disclose
 
Marcus O. Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Adaptimmune; Bristol-Myers Squibb; EMD Serono; GlaxoSmithKline; Immunocore; Immunovaccine; Merck; Novartis
Research Funding - Merck
Expert Testimony - Merck